104. The case: hemolysis and acute renal failure. Babesiosis. Kidney Int 2011; 80(6):681-683. (IF 14.8)
Blum S, Gattringer R, Haschke E, Walochnik J, Tschurtschenthaler G, Lang F, Oberbauer R.
// Publications
103. Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int. 2011; 24(9):912-219. (IF 2.7)
Kristo I, Wilflingseder J, Kainz A, Marschalek J, Wekerle T, Mühlbacher F, Oberbauer R, Bodingbauer M.
102. Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Proteomics Clin Appl. 2011 Jun;5(5-6):354-366. (IF 2.1)
Fechete R, Heinzel A, Perco P, Mönks K, Söllner J, Stelzer G, Eder S, Lancet D, Oberbauer R, Mayer G, Mayer B.
101. Linking molecular feature space and disease terms for the immunosuppressive drug rapamycin. Mol Biosyst 2011; 7(10):2863-2871. (IF 3.336)
Bernthaler A, Mönks K, Mühlberger I, Mayer B, Perco P, Oberbauer R.
100. The Effect of Fluid Intake on Chronic Kidney Transplant Failure-A Pilot Study. Jour Ren Nutr 2011; 21(6):499-505. (IF 3.4)
Magpantay L, Ziai F, Oberbauer R, Haas M.
99. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011; 26(9):2988-2995. (IF 4.8)
Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R.
98. Integrative Bioinformatics Analysis of Proteins Associated with the Cardiorenal Syndrome. Int J Nephrol 2011; 2011:id809378
Mühlberger I, Moenks K, Bernthaler A, Jandrasits C, Mayer B, Mayer G, Oberbauer R, Perco P.
96. Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies. Transpl Int 2011;24(2):143-149 (IF 2.7)
Korbély R, Wilflingseder J, Perco P, Kainz A, Langer RM, Mayer B, Oberbauer R.